SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 132 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $84,000 | +33.3% | 6,435 | +11.9% | 0.00% | – |
| Q1 2016 | $63,000 | +53.7% | 5,751 | +28.9% | 0.00% | – |
| Q4 2015 | $41,000 | +2.5% | 4,461 | -23.0% | 0.00% | – |
| Q3 2015 | $40,000 | +135.3% | 5,792 | +225.6% | 0.00% | – |
| Q2 2015 | $17,000 | +41.7% | 1,779 | +28.4% | 0.00% | – |
| Q1 2015 | $12,000 | 0.0% | 1,385 | -0.4% | 0.00% | – |
| Q4 2014 | $12,000 | 0.0% | 1,390 | -16.9% | 0.00% | – |
| Q3 2014 | $12,000 | +33.3% | 1,672 | -2.8% | 0.00% | – |
| Q2 2014 | $9,000 | +12.5% | 1,720 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | -11.1% | 1,720 | -0.2% | 0.00% | – |
| Q4 2013 | $9,000 | -70.0% | 1,723 | -70.6% | 0.00% | – |
| Q3 2013 | $30,000 | +87.5% | 5,859 | +83.2% | 0.00% | – |
| Q2 2013 | $16,000 | – | 3,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |